Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.5 (thrombin)
 33,306 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Studies from several laboratories have suggested that laminin contains at least two domains that selectively mediate cell type-specific behavior. In this study, two proteolytic fragments of laminin are evaluated for their ability to interact with three different populations of embryonic chicken cells. A 600 kDa thrombin fragment, derived from the central portion of the laminin molecule, supports attachment of dorsal root ganglion (DRG), spinal cord (SC), and heart cells. Neurons from both DRGs and SCs extend neurites in response to this fragment. Quantitatively, both cell adhesion and neurite extension on the 600 kDa fragment are comparable to these responses to intact laminin. A 440 kDa chymotrypsin fragment, derived from either intact laminin or the 600 kDa fragment, does not support equivalent responses. Fewer DRG cells attach to this fragment and neurites are shorter than on the 600 kDa fragment. Heart and SC cell attachment is also reduced in comparison with activity of the 600 kDa fragment, and SC neurites do not form on the 440 kDa fragment. These results suggest that there are at least two cell binding domains in the laminin molecule, one with which a variety of cell types can interact and another that may mediate more restricted cellular responses. The latter site appears to be relatively inactive for SC and heart cell adhesion but supports limited attachment and neurite extension by DRG neurons.
 ...
PMID:Cell adhesion and neurite extension in response to two proteolytic fragments of laminin. 321 26

Monoclonal antibodies were utilized to localize novel heparin-binding domains of laminin. A solid-phase radioligand binding assay was designed such that [3H] heparin bound to laminin in a time- and concentration-dependent manner. Tritiated heparin binding to laminin was saturable and specific as determined by competition with unlabeled heparin, dextran sulfate, and dermatan sulfate. By Scatchard analysis, two distinct dissociation constants were calculated (Kd = 50 and 130 nM), suggesting the presence of at least two binding sites for heparin on laminin. Tritiated heparin bound to thrombin-resistant (600 kDa) and chymotrypsin-resistant (440 kDa) laminin fragments, both known to lack the terminal globular domain of the long arm. Sodium dodecyl sulfate-polyacrylamide gels of chymotrypsin- and thermolysin-digested laminin chromatographed on a heparin-Sepharose column showed multiple proteolytic fragments binding to the column. Monoclonal antibodies generated against laminin were tested for their ability to inhibit [3H]heparin binding to laminin. Four monoclonal antibodies significantly inhibited the binding of [3H]heparin to laminin in the range of 15-21% inhibition. Laminin-monoclonal antibody interactions examined by electron microscopy showed that one antibody reacted at the terminal globular domain of the long arm, domain Hep-1, while epitopes for two of these monoclonal antibodies were located on the lateral arms of laminin, domain Hep-2, and the fourth monoclonal antibody bound below the cross-region of laminin, domain Hep-3. When two monoclonal antibodies recognizing distinctly different regions of laminin were added concomitantly, the inhibition of [3H]heparin binding to laminin increased almost 2-fold. These results suggest that at least two novel heparin-binding domains of laminin may be located in domains distinct from the terminal globular domain of the long arm.
 ...
PMID:Localization of three distinct heparin-binding domains of laminin by monoclonal antibodies. 335 Aug 14